Pediatric cardiology

There are number of heart conditions that can affect children. Few children have structural differences by birth others involve the electrical system that controls the heartbeat. Pediatric cardiologists mainly treat, diagnose and manage the problems in the child.  Pediatric heart problems in children, includes congenital heart disease and Arrhythmias. Congenital heart disease refers to heart structural variation by birth in child which include holes between chambers of the heart, abnormal blood vessels and valve problems. Arrhythmiasis know as abnormal heart rhythms caused by the system that controls the heart beat electrically. Pediatric cardiologists will treat pulmonary hypertension and systemic hypertension. Systemic hypertension means high blood pressure in the body. But in few regions pulmonary hypertension is treated by pediatric pulmonologists and systemic hypertension is treated by pediatric nephrologists

In Food industries generally, Pediatric cardiologists work closely with primary care pediatricians to provide coordinated and comprehensive care. Heart Problems can arise due to various other symptoms in the body so pediatric cardiologist will team up with health care providers. For child care there are pediatric heart surgeons, cardiac anesthesiologists, neonatologists, cardiac pediatric intensivists, pediatric radiologists, as well as pediatric nurses, nutritionists, and speech, occupational, and physical therapists. There are various Tools to diagnose cardiac conditions in children. Based on Physical and cardiac examination. For Physical examination: Vital signs and Cardiac examination will be carried out. For Laboratory examination: Electrocardiography, Chest X-ray , Pulse oximetry, Blood counts, Echocardiography, Magnetic resonance imaging (MRI and MRA), Computed tomography, Exercise testing, Cardiac catheterization are done. Environmental and genetic conditions associated with heart disease in children also plays major role. There are various Unusual forms of congenital heart disease in children, Unique cardiac conditions in newborn infants, cardiac conditions acquired during childhood, Abnormalities of heart rate and conduction in children and Congestive heart failure in infants and children. For preventing follow the treatment and precautions given by pediatric cardiologist and have a healthy lifestyle

Nanotechnology in Cardiology

Nanotechnology is a field of science which deals with materials in nano scale. Nano-materials display unique mechanical, electrical, chemical, and optical properties. By understanding the properties of nano materials; we can use in research, diagnosis and therapy of heart, lung, blood and sleep. Nanotechnology will offer novel techniques in the treatment of a multitude of diseases, including cardiovascular disorders. Ischemic heart conditions are some of the most prevalent disorders in many parts of the world. In each year death rate is increased significantly due to heart disease. Even-though ischemic and infarct heart disease are treated in advanced methods, it mainly leads to heart failure.

Death mainly occurs due to the inability to provide medication to the affected area, lack of stem cell implantation, tissue regeneration, and additional damage in ischemic tissue. The promising results have been shown in therapeutic environment by application of nanotechnology. Several nanotechnology based treatments for ischemic heart diseases including simple and modified drug/stem cell delivery systems ranging from magnetic, antibody-linked, and mesoporous silica nano-particles.

Nano-particles vehicles have emerged on an approach for the site-selective delivery of therapeutic agents to areas of the injured or dysfunctional vascular wall including vascular segments at risk for restenosis following per-cutaneous coronary interventions. This approach infusion allows for a targeted delivery of compounds to sites of vascular dysfunction or injury. Components of the technology include a combination of known / approved ultrasound contrast vascular imaging agents complexed with therapeutic agents. A number of therapeutic agents have been explored for incorporation into the nano-particle delivery vehicle and for efficacy on re-stenosis